Drug class in one race
RAS (pan-RAS, RAS-mutant tumors) drugs for Non-Small Cell Lung Cancer
2 tracked RAS (pan-RAS, RAS-mutant tumors) drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the RAS (pan-RAS, RAS-mutant tumors) page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 31 Phase 1/2